<SEC-DOCUMENT>0001193125-16-681349.txt : 20160815
<SEC-HEADER>0001193125-16-681349.hdr.sgml : 20160815
<ACCEPTANCE-DATETIME>20160815073732
ACCESSION NUMBER:		0001193125-16-681349
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20160815
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160815
DATE AS OF CHANGE:		20160815

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMARIN CORP PLC\UK
		CENTRAL INDEX KEY:			0000897448
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21392
		FILM NUMBER:		161830043

	BUSINESS ADDRESS:	
		STREET 1:		FIRST FLOOR, BLOCK 3, THE OVAL,
		STREET 2:		SHELBOURNE ROAD, BALLSBRIDGE
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			00000
		BUSINESS PHONE:		353 1 6699 020

	MAIL ADDRESS:	
		STREET 1:		FIRST FLOOR, BLOCK 3, THE OVAL,
		STREET 2:		SHELBOURNE ROAD, BALLSBRIDGE
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMARIN PHARMACEUTICALS PLC
		DATE OF NAME CHANGE:	20000201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ETHICAL HOLDINGS PLC
		DATE OF NAME CHANGE:	19930322
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d249637d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of Earliest Event Reported): August&nbsp;15, 2016 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Amarin Corporation plc </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>England and Wales</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>0-21392</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Not applicable</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>2 Pembroke House, Upper Pembroke Street 28-32, Dublin 2, Ireland</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Not applicable</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: +353 1 6699 020 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Not Applicable </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Former
name or former address, if changed since last report </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;8.01. Other Events </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&nbsp;15, 2016, Amarin Corporation plc (the &#147;Company&#148;) issued a press release announcing the full exercise by the
underwriters of the Company&#146;s previously announced underwritten public offering of their option to purchase an additional 3,165,000 American Depositary Shares. A copy of the press release is included as Exhibit 99.1 to this Current Report on
Form 8-K and is incorporated herein by reference. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;9.01. Financial Statements and Exhibits. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibits </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the rules&nbsp;and regulations of the
Securities and Exchange Commission, the attached exhibits are deemed to have been filed with the Securities and Exchange Commission: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:37.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit&nbsp;No.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman">Description</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release, dated August 15, 2016</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp; * </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: August&nbsp;15, 2016</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">AMARIN CORPORATION PLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John Thero</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">John Thero</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">President and Chief Executive Officer</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exhibit&nbsp;Index </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:37.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit&nbsp;No.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman">Description</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release, dated August 15, 2016</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d249637dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g249637snap10.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Amarin Announces Underwriters&#146; Exercise of Option to Purchase Additional American Depositary Shares
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BEDMINSTER, N.J., and DUBLIN, Ireland, August&nbsp;15, 2016 &#151; Amarin Corporation plc (NASDAQ: AMRN) today announced that, in connection with its
previously announced underwritten public offering of American Depositary Shares (&#147;ADSs&#148;), the underwriters of the offering have exercised in full their option to purchase up to an aggregate of 3,165,000 additional ADSs. The exercise of
this option increases the size of the offering to an aggregate of 24,265,000 ADSs at a price to the public of $2.85 per ADS. The aggregate net proceeds to the company from this offering are expected to be approximately $64.6 million, after deducting
underwriting discounts and commissions and other estimated offering expenses. The offering, including the purchase of the additional ADSs, is expected to close on or about August&nbsp;16, 2016, subject to customary closing conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jefferies LLC and Citigroup Global Markets Inc. are acting as joint book-running managers in the offering. Cantor Fitzgerald&nbsp;&amp; Co. is acting as lead
manager and H.C. Wainwright&nbsp;&amp; Co. and SunTrust Robinson Humphrey are acting as co-managers in this offering. Amarin anticipates using the net proceeds from the offering to advance its REDUCE-IT cardiovascular outcomes trial and for general
corporate and working capital purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The securities described above are being offered by Amarin pursuant to a shelf registration statement on Form S-3
(No. 333-197936) previously filed with the Securities and Exchange Commission (the &#147;SEC&#148;) on August&nbsp;7, 2014 and declared effective by the SEC on August&nbsp;22, 2014. A preliminary prospectus supplement related to the offering has
been filed with the SEC and is available on the SEC&#146;s website at http://www.sec.gov. Copies of the final prospectus supplement relating to these securities may be obtained from Jefferies LLC, Attn: Equity Syndicate Prospectus Department, 520
Madison Avenue, 2nd Floor, New York, NY 10022, by telephone at (877)&nbsp;821-7388 or by email at <U>Prospectus_Department@Jefferies.com</U> or from Citigroup Global Markets Inc., c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood,
NY 11717, by telephone at (800)&nbsp;831-9146. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release shall not constitute an offer to sell or the solicitation of an offer to buy these
securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or
other jurisdiction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About&nbsp;Amarin </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amarin
Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Vascepa<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (icosapent ethyl) capsules,
Amarin&#146;s first FDA approved product, are a highly-pure, omega-3 fatty acid product available by prescription. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Disclosure Notice </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This press release contains forward-looking statements, within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of
1995. Statements that are not historical facts, including statements related to Amarin&#146;s public offering of American Depositary Shares, are forward-looking statements that involve risks and uncertainties. Words such as &#147;intends,&#148;
&#147;plans,&#148; &#147;expects,&#148; &#147;may,&#148; &#147;will&#148; and similar expressions are intended to identify forward-looking statements. These forward-looking statements are not promises or guarantees. These forward-looking statements
are based upon Amarin&#146;s current expectations. Actual events and results and the timing of events and results could differ materially from those anticipated in such forward-looking statements. Among the factors that could cause actual results to
differ materially from those described or projected herein are the following: risks related to the underwriters&#146; consummation of their obligation to purchase the securities, whether Amarin will be able to satisfy its obligations to close the
offering and the risk that Amarin will not use the proceeds from the offering in the manner contemplated, as well as the risks, uncertainties and other matters detailed in Amarin&#146;s filings with the U.S. Securities and Exchange Commission,
including its most recent Annual Report on Form 10-K, its most recent Quarterly Report on Form 10-Q and the preliminary prospectus supplement relating to the offering and filed on August&nbsp;10, 2016. Existing and prospective investors are
cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they were made. Amarin undertakes no obligation to update or revise the information contained in this press release, whether as a result of
new information, future events or circumstances or otherwise, except as required by law. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amarin contact information: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Investor Relations: </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kathryn McNeil</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor Relations and Corporate Communications </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amarin
Corporation plc </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In&nbsp;U.S.: +1 (908)&nbsp;719-1315 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>investor.relations@amarincorp.com</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lee M. Stern </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Trout Group </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In&nbsp;U.S.: +1 (646)&nbsp;378-2992 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>lstern@troutgroup.com</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Media Inquiries: </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kristie Kuhl </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Finn Partners </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In&nbsp;U.S.: +1 (212)&nbsp;583-2791 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Kristie.kuhl@finnpartners.com</U> </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g249637snap10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g249637snap10.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /?Z "@ H * "@ H C%Q ;@VXF3SPN\Q[AN"YQG'7&>] $E
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 E(84 % !0!Q'C[XB6GA"#[) HN-6D3='$0=J#^\Q
M_IWJXQN+8\6\.^-[_3?'$?B"_N'G:9MMUG^*,]0![<$#VK9Q35D*Y].PRQSP
MI-$X>.10RL.A!Y!KF*'T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % "TQ!0 E(84 % !0!X+\6[I_$/BB
M6TTVU\X:+;%KJ9!R 2,@^RY'YFMX:(EGEU:B/??@UXI_M/0VT.Y?-UIXS&2>
M6B)X_(\?3%<]2-G<I'IU9C"@ H * "@ H * "@ H * "@ H * "@ H * "@
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M+E\,^(OLUY-LTV^PDA)X1_X6]O0_7VJ9QN@1]$W,B+8S2%E$8C9MV>,8ZYK
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M\1V26MS=7EO&C[\VLQB+<8P2.HIIV Y%O@KX6=BSRZBS$Y+-<Y)/UQ5>T8K
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'0 4 % '_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
